Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Pipeline Review, H2 2016 - Key Players are Axxam, Grunenthal & Boehringer Ingelheim - Research and Markets

Research and Markets
Posted on: 18 Oct 16

Research and Markets has announced the addition of the "B1 Bradykinin Receptor (BK1 Receptor or BDKRB1) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for B1 Bradykinin Receptor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for B1 Bradykinin Receptor and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Axxam SpA
  • Boehringer Ingelheim GmbH
  • Dompe Farmaceutici S.p.A.
  • Grunenthal GmbH

Key Topics Covered:

  • Introduction
  • B1 Bradykinin Receptor Overview
  • Therapeutics Development
  • Pipeline Products for B1 Bradykinin Receptor - Overview
  • Pipeline Products for B1 Bradykinin Receptor - Comparative Analysis
  • B1 Bradykinin Receptor - Therapeutics under Development by Companies
  • B1 Bradykinin Receptor - Therapeutics under Investigation by Universities/Institutes
  • B1 Bradykinin Receptor - Pipeline Products Glance
  • Late Stage Products
  • Clinical Stage Products
  • Early Stage Products
  • B1 Bradykinin Receptor - Products under Development by Companies
  • B1 Bradykinin Receptor - Products under Investigation by Universities/Institutes
  • B1 Bradykinin Receptor - Companies Involved in Therapeutics Development

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/kwx3r3/b1_bradykinin

View source version on businesswire.com: http://www.businesswire.com/news/home/20161018006333/en/

Business Wire
www.businesswire.com

Last updated on: 18/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.